FinTechFunding

Telix Pharmaceuticals: Signs multimillion-dollar strategic partnership

  • Telix Pharmaceuticals (TLX) has entered a multimillion-dollar strategic partnership with China Grand Pharmaceutical and Healthcare Holdings (CGP)
  • The products are used in medical imaging of the brain, prostate, and renal cancer
  • The partnership will have a 10-year term, following the granting of marketing authorization for each product
  • Telix Pharmaceuticals CEO Dr. Chris Behrenbruch said the company believes CGP is the ideal partner for the region
  • CGP will also make a strategic investment in Telix which will secure it a 7.62 percent interest in the company
  • TLX shares closed 29 percent higher at $2.16
Previous article
PayGroup: Appoints Shane Gild as Non-Executive Director
Next article
UnitedFCU: Unifies Core and Card Capabilities with Fiserv
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

eToro Strengthens Crypto Portfolio with Zengo Acquisition

Deal expands eToro's offerings in the cryptocurrency sector.Highlights: eToro is acquiring crypto wallet Zengo to expand its services.The...
FinTech

Revolut Launches Platform to Streamline Overseas Talent Hiring

Revolut's new service aims to simplify global recruitment for businesses.Highlights: Revolut launches a platform for hiring overseas talent.The...
FinTech

Revolut Strengthens Business Recruitment Platform in New Markets

The fintech giant expands its offerings targeting recruitment needs globally.Highlights: Revolut enhances its platform for business recruitment.The expansion...
FinTech

UniCredit Selects Slate to Strengthen Retail Investment Services

The partnership aims to enhance digital investment options for customers.Highlights: UniCredit partners with Slate for enhanced retail investment...